Health

Anvisa temporarily suspends Coronavac clinical trial | Vaccine

[ad_1] The National Sanitary Surveillance Agency (Anvisa) has temporarily suspended human testing of the Chinese Coronavac vaccine. The interruption occurred due to a “serious adverse event” and was announced this Monday (9). This is one of the candidates for the coronavirus vaccine and is developed by the Chinese laboratory Sinovac …

Read More »